Literature DB >> 25436675

The versatile regulation of cellular events by Jak-Stat signaling: from transcriptional control to microtubule dynamics and energy metabolism.

Bernd Groner, Lothar Hennighausen.   

Abstract

Year:  2012        PMID： 25436675     DOI： 10.1515/hmbci-2012-0010

Source DB:  PubMed          Journal:  Horm Mol Biol Clin Investig        ISSN： 1868-1883


× No keyword cloud information.
  6 in total

1.  Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells.

Authors:  Axel Weber; Corina Borghouts; Christian Brendel; Richard Moriggl; Natalia Delis; Boris Brill; Vida Vafaizadeh; Bernd Groner
Journal:  Cancers (Basel)       Date:  2015-03-19       Impact factor: 6.639

2.  Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops.

Authors:  Viktoria von Manstein; Chul Min Yang; Diane Richter; Natalia Delis; Vida Vafaizadeh; Bernd Groner
Journal:  Curr Signal Transduct Ther       Date:  2013-12

Review 3.  Mesenchymal stem/stromal cells in cancer therapy.

Authors:  Tianxia Lan; Min Luo; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-11-17       Impact factor: 17.388

4.  The inhibition of stat5 by a Peptide aptamer ligand specific for the DNA binding domain prevents target gene transactivation and the growth of breast and prostate tumor cells.

Authors:  Axel Weber; Corina Borghouts; Christian Brendel; Richard Moriggl; Natalia Delis; Boris Brill; Vida Vafaizadeh; Bernd Groner
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-20

5.  Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular Oncology.

Authors:  Bernd L Groner; Nancy E Hynes
Journal:  PLoS Biol       Date:  2016-09-29       Impact factor: 8.029

6.  Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib.

Authors:  V von Manstein; B Groner
Journal:  Medchemcomm       Date:  2016-10-14       Impact factor: 3.597
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.